(Q37952604)

25 August 2017

title

Atrial fibrillation and heart failure in the elderly (English)

1 reference

25 August 2017

0 references

0 references

Pedram Kazemian

1

1 reference

25 August 2017

Gavin Oudit

series ordinal

2

1 reference

25 August 2017

Bodh I Jugdutt

series ordinal

3

1 reference

25 August 2017

language of work or name

1 reference

1 September 2012

1 reference

25 August 2017

published in

Heart Failure Reviews

1 reference

25 August 2017

volume

17

1 reference

25 August 2017

issue

4-5

1 reference

25 August 2017

page(s)

597-613

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-011-9290-y

25 August 2017

exact match

0 references

cites work

Incidence of and risk factors for atrial fibrillation in older adults.

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

The epidemiology of atrial fibrillation in elderly persons: the tip of the iceberg

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Atrial fibrillation in elderly patients: prevalence and comorbidity in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

The incidence of asymptomatic paroxysmal atrial fibrillation in patients treated with propranolol or propafenone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Atrial fibrillation is associated with accumulation of aging-related common type mitochondrial DNA deletion mutation in human atrial tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Atrial and ventricular arrhythmias in asymptomatic active elderly subjects: correlation with left atrial size and left ventricular mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Aging dilates atrium and pulmonary veins: implications for the genesis of atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

The effects of aging on atrial endocardial electrograms in patients with paroxysmal atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Stroke severity in atrial fibrillation. The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Heart failure in the elderly: advances and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

STEMI and heart failure in the elderly: role of adverse remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Aging and remodeling during healing of the wounded heart: current therapies and novel drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Plasma and cardiac tissue atrial and brain natriuretic peptides in experimental heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Pacing-induced heart failure: a model to study the mechanism of disease progression and novel therapy in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Cosecretion of atrial and brain natriuretic peptides during supraventricular tachyarrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Tachycardia-induced diastolic dysfunction and resting tone in myocardium from patients with a normal ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Recommendations for the evaluation of left ventricular diastolic function by echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Unequal atrial stretch in dogs increases dispersion of refractoriness conducive to developing atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Association of echocardiographic atrial size and atrial fibrosis in a sequential model of congestive heart failure and atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Remodeling of the myocardium and potential targets in the collagen degradation and synthesis pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Randomized trial of rhythm or rate control in atrial fibrillation: the Pharmacological Intervention in Atrial Fibrillation Trial (PIAF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

A comparison of rate control and rhythm control in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Rhythm control versus rate control for atrial fibrillation and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Sex difference in risk of torsade de pointes with d,l-sotalol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Is antiarrhythmic treatment in the elderly different? a review of the specific changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Dofetilide in patients with congestive heart failure and left ventricular dysfunction: safety aspects and effect on atrial fibrillation. The Danish Investigators of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Chronic and acute effects of dronedarone on the action potential of rabbit atrial muscle preparations: comparison with amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

New and emerging antiarrhythmic and anticoagulant agents for atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Increased mortality after dronedarone therapy for severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Effect of dronedarone on cardiovascular events in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Cardiovascular drug therapy in the elderly: theoretical and practical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Population pharmacokinetics of intravenous amiodarone and comparison with two-stage pharmacokinetic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Antithrombotic prophylaxis in elderly patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Dabigatran versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Catheter ablation for atrial fibrillation in congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Ablate and pace strategy for atrial fibrillation: long-term outcome of AIRCRAFT trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Clinical outcomes after ablation and pacing therapy for atrial fibrillation : a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Long-term effect of right ventricular pacing on myocardial perfusion and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Pulmonary-vein isolation for atrial fibrillation in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Alterations in serum sodium in relation to atrial natriuretic factor and other neuroendocrine variables in experimental pacing-induced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Long-Term Mechanical Consequences of Permanent Right Ventricular Pacing: Effect of Pacing Site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9290-Y

Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort

21 January 2018

1 reference

12 December 2020

Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications

1 reference

12 December 2020

Clinical safety profile of sotalol in patients with arrhythmias

1 reference

12 December 2020

Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation

1 reference

12 December 2020

Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery

1 reference

12 December 2020

Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'

1 reference

12 December 2020

Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function

1 reference

12 December 2020

Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

1 reference

12 December 2020

Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation

1 reference

12 December 2020

Atrial fibrillation and mortality in an elderly population

1 reference

12 December 2020

Contractile and cytoskeletal content, structure, and mRNA levels with tachycardia-induced cardiomyopathy

1 reference

12 December 2020

A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation

1 reference

12 December 2020

Cellular and extracellular remodeling with the development and recovery from tachycardia-induced cardiomyopathy: changes in fibrillar collagen, myocyte adhesion capacity and proteoglycans

1 reference

12 December 2020

The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study

1 reference

12 December 2020

Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left V

1 reference

12 December 2020

Atrial contraction is an important determinant of pulmonary venous flow

1 reference

12 December 2020

Downregulation of angiotensin converting enzyme II is associated with pacing-induced sustained atrial fibrillation

1 reference

12 December 2020

The hemodynamic consequences of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model

1 reference

12 December 2020

2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline)

1 reference

12 December 2020

Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm

1 reference

12 December 2020

Adverse effects of low dose amiodarone: a meta-analysis

1 reference

12 December 2020

Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study

1 reference

12 December 2020

Influence of atrial systole on the Frank-Starling relation and the end-diastolic pressure-diameter relation of the left ventricle

1 reference

12 December 2020

Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study

1 reference

12 December 2020

Effects of Advancing Age on the Efficacy and Side Effects of Antiarrhythmic Drugs in Post-Myocardial Infarction Patients with Ventricular Arrhythmias

1 reference

12 December 2020

Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators

1 reference

12 December 2020

Effect of an irregular ventricular rhythm on cardiac output

1 reference

12 December 2020

Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study)

1 reference

12 December 2020

Etiology and complications of atrial fibrillation: insights from pathology studies

1 reference

12 December 2020

The potentiation of warfarin anticoagulation by amiodarone

1 reference

12 December 2020

Increased expression of extracellular matrix proteins in rapid atrial pacing-induced atrial fibrillation

1 reference

12 December 2020

Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients.

1 reference

12 December 2020

Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation

1 reference

12 December 2020

Understanding digoxin use in the elderly patient

1 reference

12 December 2020

Effects of experimental heart failure on atrial cellular and ionic electrophysiology

1 reference

12 December 2020

Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients

1 reference

12 December 2020

Echocardiographic assessment of a normal adult aging population

1 reference

12 December 2020

JTc prolongation with d,l-sotalol in women versus men

1 reference

12 December 2020

Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials

1 reference

12 December 2020

Long-term survival following radiofrequency catheter ablation of atrioventricular junction for atrial fibrillation: clinical and ablation determinants of mortality

1 reference

12 December 2020

10.1007/S10741-011-9290-Y

Identifiers

DOI

1 reference

release_na3l2qeay5f4rgpocztj7jwyui

25 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/na3l2qeay5f4rgpocztj7jwyui

24 November 2022

mapped directly with Wikidata item

1 reference